Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

I think it gets a bit complicated having patients enroll for a double blind, randomized multi-site test. Enrolled patients have to agree to either get the new drug (Brilicidin) or standard of care, which is what? Remdesivir? Clorox? (ok, guess not), anti-bodies, steroids, etc. in standardized amounts which do vary by age, weight, previous conditions, etc. Not as easy as it seems, though, since it is not a cancer test, making it a lot easier, especially since most hospital patients are already on some sort of iv. As often noted, the tests should go quickly, but it is the prelim that takes time. Which is probably why AF in Italy has not begun reporting on the IBD UP/UPC tests of Brilicidin it licensed last year, at leas I am hoping that the pandemic and its "restart" is what is holding up the reporting of test starts.